American Cannabis News

Curaleaf Q2 Revenue Falls 8% – New Cannabis Ventures

Published

6 months ago

August 17, 2025

admin

Curaleaf Q2 Revenue Falls 8% – New Cannabis Ventures

August 6, 2025, 4 pm. At 25

Published by NCV NewsWire

Curaleaf reports 2025 results of the second quarter. Internal stabilization, strong international momentum

The second quarter 2025 total income of $ 315 million
The second quarter of 2025 international income, $ 41 million
The second quarter 2025 adjusted gross margin 49%
He was awarded at the NASCENT MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTIONAL MESTION

Stamford, Conn., 6, 2025 / PRNEWSWIRE / – Curaleaf Holdings, Inc. (TSX: Cura) (otcqx: Curaleaf or Curaleaf, the leading international supplier of consumer goods at Cannabis, reports that it is planned for the last second quarter, unless otherwise stated.

Kuralef President and Chief Executive Director Boris Jordan, the income of the second quarter, compared to the first quarter, was 66 million dollars for the previous quarter. Growth We ended Q2 with $ 102 million in cash, $ 47 million, and debt payment. “

Mr. Jordan continued. The growth. Through the collection of assets built and the asset database, we are now tightening our attention to the quality of the quality of the product, customer service and chain of excellence.

Second quarter 2025 Financial importance

A net income worth $ 314.5 million, a year annually, is 8% compared to 342.3 million dollars in the quarter of 8224. Sequential, net income increased by 1.5% compared to 310.0 million US dollars in 2025
Gross profit: $ 152.6 million and gross margin, 49%, 160 basic points per year
Adjusted gross profit of $ 153.5 million and adjusted gross margin (1) 49%, 120 base scores increase
Net loss attributed to Curaleaf Holdings, Inc. $ 50.6 million or net loss from one share of $ 0.07 on continuous activities
Adjusted net losses from $ 47.8 million to one share of $ 0.06 per share
Adjusted eBitda¹ is $ 65.5 million
At the end of the quarter was $ 102.3 million

Original press release

Published by NCV NewsWire

NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number

Related Topics:Cannabis Curaleaf Falls Revenue Ventures

Up Next

Tilray Is a Dangerous Stock – New Cannabis Ventures

Don't Miss

IIPR Extends Beyond Cannabis – New Cannabis Ventures

American Cannabis Coverage by State

Cannabis Sales Slipped in January – New Cannabis Ventures

Published

2 days ago

February 4, 2026

admin

Cannabis Sales Were Soft Again – New Cannabis Ventures

On February 3, 2026 at 8:42 PM

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s 15-state monthly cannabis sales data.

In January, cannabis sales decreased sequentially by 3.1%. In this review, we break down the results by state, starting with the western markets and then ending with the eastern markets. Overall, the BDSA estimates sales in 15 markets totaled $2.07 billion in January, up 4.6 percent from a year earlier. BDSA updated its Illinois numbers after the state recently changed the way it counts sales.

Western markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In December, annual growth was negative in 4 states. Growth in each of these states fell in succession.

Eastern markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. Annual growth in December ranged from -3.1% in Missouri to +37.6% in New York. Ohio began using adults in August, spurring growth. Note that Florida and Pennsylvania are medical markets only. On a daily basis, sequential gains declined in eight markets. Annual growth was negative in both markets and sharp in both states. We warned of a potential slowdown in Florida despite strong dispensary and unit volume growth due to competitive pressure.

For readers interested in a deeper look hemp markets in these fifteen states and more, including segmentation by additional product categories, brand and product details, longer history and segmentation by product attributes, learn how BDSA Solutions can give you access to actionable data and analytics.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

In this article.

Arizona, bdsa, California, cannabis data analysis, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, New York, Ohio, Oregon, Pennsylvania

4Front

Illinois Provides Another Cannabis Update – New Cannabis Ventures

Published

5 days ago

February 1, 2026

admin

Illinois Cannabis Data Change Suggests Much Lower Sales – New Cannabis Ventures

February 1, 2026 at 3:27 p.m

Illinois released sales figures for two months on Friday. The last time it released the data in November, the state did a major review of historical sales after a long delay, and it was updated to October. The previous report was for Cannabis for adults in May. The November document explained that the lack of data was due to the Metrc transition. “Sales tracking features in Metrc help retailers more accurately and reliably report actual sales, including all discounts and promotions at checkout. A careful review of past data shows that some initial discount prices were collected in previous months.” Here is the updated data until the end of 2025.

Statewide adult cannabis sales rose 5.6% sequentially to $116.6 million in December, up 2.2% on the day. Year-on-year growth was -23.9%, a slight improvement from November’s -26.1% growth. Here is a chart of adult sales over time:

After growing 106% in 2021, 13% in 2022 and 5% in 2023, annual sales for adults are set to grow 5.4% to $1.72 billion in 2024. In 2025, they decreased by 12.5% to $1.51 billion, which was lower than the total in 2022.

There hasn’t been an update from the state on medical cannabis in a while. The state exempts the sale separately from its medical plan, and April issue showed that sales fell 1.6% sequentially to $19.7 million, down 13.2% year over year.

In this article.

4 Front, Aaaaaah, rise to health, ayr health, AYRWF:, Cannabist, cbst:, cbstf:, cl:, Cresco Labs, CRLBF:, treatment, Curaleaf:, curly, flight, ffntf:, Green Thumb Industries, gtbif:, gti:, Illinois, YOU:, jusf, jushi, embodied, mrmd:, Planet 13:, plnh, PLTH:, summer, WITH:, vrnoff:

American Cannabis News

A Very Large MSO Is Now Extending Its Business – New Cannabis Ventures

Published

6 days ago

January 31, 2026

admin

You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.

friends,

This week, Scotts Miracle-Gro, the largest stock in the Global Hemp Stock Index by market capitalization, announced that it has found a buyer for its Hawthorne Gardening Company business in Vireo Growth. This news first appeared in an online article published by the Wall Street Journaland then Vireo issued a press release like Scotts Miracle-Gro, which also reported in its fiscal 1st quarter.

The deal is not a done deal. Vireo called it a “non-binding memorandum of understanding” but did not discuss the terms of the deal or when it might close. Scotts Miracle-Gro, which had already told investors it was working on this type of deal, did not disclose Hawthorne’s financial results for the 1st quarter. Analysts didn’t really ask any questions about it during the conference. The WSJ article said Vireo is giving Scotts Miracle-Gro 13% of its stock in return, but neither company has disclosed that in their press releases or SEC filings.

I include SMG in my 420 Investor Focus List, but Vireo is not a member of that group. Vireo also failed to qualify for the Global Cannabis Stock Index due to its low trading volumes. As I detailed five weeks ago, The Vireo has grown very large in terms of revenue and its geographic focus. The stock was then at $0.625 and is now lower, closing at $0.55. On Christmas Eve, the decline was 12.0%, while the MSOS fell 10.1%.

Maybe investors are interested in this deal and I’m not. First, it’s not a done deal. Second, to purchase Hawthorne, the investor must assume 280E taxation risk. Third, the price seems high, as 13% of the company is worth about $75 million. Fourth, it’s not clear to me that marrying a hemp operator with a subsidiary makes sense as I recall TILT Holdings.

I have followed Hawthorne Gardening for a long time and am glad that CEO Hagedorn and his team have gone ahead and purchased it and expanded it. The hemp industry has been struggling for about five years, and the big drop in Hawthorne Gardening’s revenue is not SMG’s fault in my opinion. It’s not clear to me how Vireo Growth will make it a better action, but I hope it has a good plan.

I continue to believe that investors should pay close attention to what is happening with shares in Vireo. This potential acquisition was not something that was discussed by analysts or investors, but today’s volume of 277 thousand shares was very low. Once again, Vireo, thanks to its aggressive M&A activity, has become the 7th largest MSO in the NCV Revenue Tracker. It remains very troubling to me that stocks are not earning a lot of interest.

Sincerely,

Alan:

New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we published last week.

Exclusives

Canadian cannabis sales were abolished in November

Follow Alan for real-time updates X.com:. Share and discover industry news with like-minded people on the largest group of cannabis investors and entrepreneurs LinkedIn:.

View: Public Hemp Company Revenue and Earnings Trackingwhich ranks the highest-earning hemp stocks.

Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.